Bausch Health Companies | VRX - Debt

Stock Price
7.84
Daily Change
0.07 0.90%
Monthly
-25.83%
Yearly
-16.33%
Q1 Forecast
7.62

Bausch Health Companies reported $21.74B in Debt for its fiscal quarter ending in June of 2025.





Debt Change Date
Amgen USD 54.59B 1.62B Sep/2025
ANI Pharmaceuticals USD 620.31M 1.25M Sep/2025
Aurora Cannabis CAD 100.34M 1.29M Sep/2025
Bausch Health Companies USD 21.74B 228M Jun/2025
Biogen USD 6.29B 309.5M Sep/2025
Bristol-Myers Squibb USD 51.04B 112M Sep/2025
Canopy Growth CAD 259.33M 68.47M Sep/2025
Corcept Therapeutics USD 6.6M 2.03M Jun/2025
Danaher USD 18.42B 1.56B Dec/2025
Drreddys Laboratories INR 67.73B 19.09B Dec/2025
Eli Lilly USD 42.51B 2.6B Sep/2025
Gilead Sciences USD 24.95B 6M Jun/2025
Novo Nordisk DKK 118.72B 61.75B Mar/2025
Pacira USD 376.72M 203.77M Sep/2025
Perrigo USD 3.65B 454.7M Jun/2025
Prestige Brands USD 1.04B 1.7M Sep/2025
Supernus Pharmaceuticals USD 31.77M 531K Jun/2025
Vertex Pharmaceuticals USD 1.53B 121.7M Jun/2025
Zoetis USD 6.79B 1.11B Jun/2025